In a world first, China has approved a brain implant for commercial use in people with spinal cord injuries. The device is a type of brain-computer interface (BCI) and is made by the Shanghai-based ...

How can rapid advancements in medical technology, questions about the criteria for brain death and the rise of transhumanism ...

China has taken a major step into the emerging field of neurotechnology by approving its first implantable brain computer interface (BCI) ...

To the naked eye, Annie Kathuria’s experiments look a bit like tiny tufts of cotton floating in pink Petri dishes. These unassuming orbs are clusters of millions of human brain cells called brain ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

OpenAI has become the lead investor in Merge Labs, a new brain-computer interface research lab co-founded by Sam Altman that just raised around $250 million USD in seed funding Merge Labs is ...

OpenAI (OPENAI) announced on Thursday that it has invested in brain computer interface startup Merge Labs, which includes OpenAI CEO Sam Altman as an investor. Brain computer interfaces, or BCIs, ...

This perspective article explores the transformative potential of brain–Computer Interfaces (BCI) in undergraduate systems engineering programs, a domain characterized by high attrition and a widening ...

BENGALURU, Dec 31 (Reuters) - Elon Musk's brain implant company Neuralink will start "high-volume production" of brain-computer interface devices and move to an entirely automated surgical procedure ...

OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...

Li Xue (left) and Zhao Zhengtou (center), co-founders of StairMed, conduct preoperative planning with Lu Junfeng at Huashan Hospital, Fudan University. The team was preparing for a clinical trial ...